ADTX
Aditxt Inc.
NASDAQ: ADTX · HEALTHCARE · BIOTECHNOLOGY
$0.22
-0.73% today
Updated 2026-04-29
Market cap
$196180.00
P/E ratio
—
P/S ratio
61.40x
EPS (TTM)
$-9,230.64
Dividend yield
—
52W range
$0 – $2,495
Volume
1.8M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+5.0
Quality
C+2.5
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$61.00
+28023.56%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-9.26M
- Revenue declining -86.60% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $933715.00 | $645176.00 | $133985.00 | $3.19M | $3195.00 |
| Net income | $-27.65M | $-32.38M | $-34.45M | $-43.10B | $-43.06B |
| EPS | — | — | — | — | $-9,230.64 |
| Free cash flow | $-22.76M | $-18.59M | $-16.76M | $-25.70B | $-9.26M |
| Profit margin | -2,961.29% | -5,018.92% | -25,708.85% | -1,349,028.20% | — |
Peer comparison
Smart narrative
Aditxt Inc. trades at $0.22. Our Smart Value Score of 23/100 indicates the stock is weak. TTM revenue stands at $3195.00.
Frequently asked questions
What is Aditxt Inc. 's stock price?
Aditxt Inc. (ADTX) trades at $0.22.
Is Aditxt Inc. overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell).
What is the price target of Aditxt Inc. (ADTX)?
The analyst target price is $61.00, representing +28023.6% upside from the current price of $0.22.
What is Aditxt Inc. 's revenue?
TTM revenue is $3195.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio61.40x
ROE-699.00%
Beta1.40
50D MA$1.75
200D MA$312.73
Shares out0.00B
Float0.00B
Short ratio—
Avg volume1.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—